Editor's Note
The Food and Drug Administration (FDA) on February 8 identified the recall by Universal Meditech Inc of its Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) as Class I, the most serious.
The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA.
Distribution dates were January 2022.
Read More >>The healthcare sector has begun grappling with a repeat challenge…
The COVID-19 pandemic has amplified existing personnel shortages in hospitals and…
Healthcare facilities face challenges in the recall process of tissue,…